MESSI-10

Treatment of osteoporosis in postmenopausal women to prevent fractures.
Treatment of osteoporosis in men to prevent fractures.
Treatment of glucocorticoid-induced osteoporosis and Prophylaxis of osteoporosis in postmenopausal women at risk of the disease.
Risk factors often associated with the development of osteoporosis include thin body build, family history of
osteoporosis, early menopause, moderately low bone mass and long-term glucocorticoid therapy, especially with high doses (15 mg/day).

This is only the preview. Please check here for the full indication.

Anatomical Therapeutic Chemical: M
Dosage form: Film coated tablet
Packaging: 10's x 3
Therapeutic area: Active pharmaceutical ingredient: